Through
1/1
Researchers at Penn Medicine are working to understand how the COVID-19 virus works, and are finding it has unusual range in symptoms and behavior, including a loss of smell in some patients.
Putting some of their regular research projects on the back burner, researchers around Penn are digging into unknowns about the novel coronavirus from their deep and varied perspectives.
Canine surveillance could play key role as the United States reopens and anticipates possible second wave amid virus fears.
The Penn Wharton Budget Model analyzed the health and economic effects of states both partially and fully reopening schools, businesses and restaurants.
Penn experts discuss the limitations of commercial antibody tests, how scientists are assessing the true scale of COVID-19 infections, and what studies are being done to see who might now be immune to the novel coronavirus.
School of Nursing faculty member and LDI Senior Fellow Adriana Perez conducts research in two of the Philadelphia area’s largest Latino communities and provides insights into how COVID-19 is impacting each.
Wharton professor Adi Wyner digs into the statistics about the COVID-19 outbreak and offers insights into what the numbers mean.
A two-part research initiative using plasma from people who’ve recovered from the virus will investigate how the therapy works for moderately and severely ill patients.
Penn Medicine launches an international trial to study whether the medications are beneficial or harmful in the treatment of hospitalized patients.
In the face of a pandemic that has shuttered most physical laboratories across campus, researchers have shifted gears, maintaining work and social ties through grant- and manuscript-writing, virtual journal clubs, online coffee breaks, and more.
Penn is lauded for its research and development efforts, including the modified mRNA technique that was commercialized into a COVID vaccine and won its researchers a Nobel Prize last year.
FULL STORY →
Ken Cadwell of the Perelman School of Medicine studies how COVID affects the gut and explains you will feel the illness in other parts of your body and not just your lungs.
FULL STORY →
Nobel laureates Katalin Karikó and Drew Weissman of the Perelman School of Medicine appear on “Sunday Morning” to discuss their careers, their mRNA research, and the COVID-19 vaccines.
FULL STORY →
A paper co-authored by Penn researchers found that COVID-19 deaths in the U.S. were likely undercounted in official statistics during the first 30 months of the pandemic.
FULL STORY →
Katalin Karikó and Drew Weissman of the Perelman School of Medicine are noted for receiving awards from the Franklin Institute and subsequently being honored with a Nobel Prize.
FULL STORY →
Drew Weissman of the Perelman School of Medicine, who won the Nobel Prize along with Katalin Karikó, discusses the backlash against vaccinations and whether to receive the latest COVID vaccine.
FULL STORY →